Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

The 2010s: A Decade Of Acceleration, Innovation And Controversy

Oncology And Rare Diseases Boom

Dec 31 2019

• By Andrew McConaghie

Related Content

An About Face As Biogen Says It Will File Aducanumab In Alzheimer’s

Oct 23 2019

Purdue Pharma: From Blockbuster Success To Bankrupt Villain

Sep 16 2019

Surprise As FDA Approves Sarepta’s Duchenne Drug Vyondys 53

Dec 13 2019

Related Companies

Merck & Co., Inc.

Novartis AG

Additional Topics

Approvals FDA Gene Therapy ImmunoOncology Innovation Personalized Medicine Research & Development BioPharmaceutical

More from New Products

More from Scrip

Twitter feed RSS feed RSS feed

About UsOpens in new window
Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us
Customer Service
Subscribe
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window